BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24410881)

  • 1. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
    Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
    Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
    Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
    Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.
    Johansson PI; Sørensen AM; Perner A; Welling KL; Wanscher M; Larsen CF; Ostrowski SR
    Crit Care; 2011; 15(6):R272. PubMed ID: 22087841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis.
    Koyama K; Madoiwa S; Tanaka S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Nunomiya S; Sakata Y
    J Crit Care; 2013 Oct; 28(5):556-63. PubMed ID: 23583072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
    Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
    Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttrauma coagulation and fibrinolysis.
    Gando S; Tedo I; Kubota M
    Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
    Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
    J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.
    Yanagida Y; Gando S; Sawamura A; Hayakawa M; Uegaki S; Kubota N; Homma T; Ono Y; Honma Y; Wada T; Jesmin S
    Surgery; 2013 Jul; 154(1):48-57. PubMed ID: 23684364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
    Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
    Xu Y; Zhu R; Sun Y; Li X; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.
    Yamakawa K; Yoshimura J; Ito T; Hayakawa M; Hamasaki T; Fujimi S
    Thromb Haemost; 2019 Feb; 119(2):203-212. PubMed ID: 30593085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.